Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 446, 145-146 (8 March 2007) | doi:10.1038/446145a; Published online 7 March 2007
Open Innovation Challenges
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
- More Challenges
- Powered by:
nature jobs
Copy Editor
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
Postdoctoral Position
- Max-Planck-Institute (MPI) of Immunobiology
- Freiburg Germany
Cancer: Drivers and passengers
Daniel A. Haber1 & Jeff Settleman1
Abstract
Studies that have provided the first unbiased, large-scale analyses of DNA mutations across an array of cancers also have lessons for the proposal to annotate the entire cancer genome.
Cancer results from an accumulation of mutations and other heritable changes in susceptible cells. So far, abnormalities in about 350 genes have been implicated in human cancers, but the true number of 'cancer genes' is unknown.
- Daniel A. Haber and Jeff Settleman are at the Massachusetts General Hospital Cancer Center and Harvard Medical School, Building 149–7, Charlestown, Massachusetts 02129, USA.
Email: haber@helix.mgh.harvard.edu
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Research HighlightsNature Biotechnology News and Views (01 Apr 2007)
Research HighlightsNature Biotechnology News and Views (01 Apr 2007)
RESEARCH
Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3BOncogene Original Article
